17.3 C
London
Wednesday, November 5, 2025
HomeBusinessZeptoMetrix Unveils PROtrol: Ensuring Quality Control for Lateral Flow Immunoassay Market

ZeptoMetrix Unveils PROtrol: Ensuring Quality Control for Lateral Flow Immunoassay Market

Date:

Related stories

Jon Wheeler: Recovery Strategies for Climbers After Intense Sessions

Based in Virginia Beach, Jon Wheeler is a seasoned...

Froda Teams Up with Triffin to Offer £100M in Embedded Finance for UK SMEs

Embedded finance provider Froda has partnered with UK-based AI...

How A Brand Relaunch Drives 25% Growth For A Food Brand

Brand Relaunch Drives 25% Growth for White Rabbit Pizza...

Project Better Energy Expands with Acquisitions of Photon Energy and EG Solar

Project Better Energy (PBE), one of the UK’s leading...

W7Worldwide Celebrates Abdulrahman Inayat Named PR Leader of the Year by ICCO

W7Worldwide proudly announces that Abdulrahman Inayat has been recognized...

ZeptoMetrix® is delighted to introduce PROtrol TM, a groundbreaking range of products specifically designed for antigen-based diagnostic methods. These meticulously crafted third-party materials accurately replicate clinical specimens and serve as vital tools for assessing and monitoring the performance of antigen-based assays, including lateral flow immunoassays for infectious diseases.

PROtrol stands as the sole whole organism reference material that offers comprehensive testing data. Each product batch is accompanied by detailed protein concentration and TCID50 value information, significantly reducing qualification testing requirements. By providing enhanced reproducibility, PROtrol optimizes financial resources and processing time by minimizing the need for repeat testing.

Dr. Karuna Sharma, Vice President & Chief Scientific Officer, expressed, “The rapid growth in antigen-based assays has brought attention to quality challenges. Inactivated, whole organism controls specifically designed for antigen tests empower manufacturers with the necessary tools to evaluate the performance of their assays, resulting in higher-quality tests available in the market.”

The inaugural member of the PROtrol product line is PROtrol SARS-Related Coronavirus 2 (SARS-CoV-2) Isolate: USA-WA1/2020* (PROSARS(COV2)-587). As we move beyond the COVID-19 pandemic, ZeptoMetrix remains committed to expanding the PROtrol product line, catering to assay manufacturers seeking affordable and user-friendly diagnostic solutions.

Evangeline Gonzalez, President of Antylia Diagnostics division, remarked, “The launch and expansion of PROtrol further solidify our position as the preferred partner for diagnostic test developers. As we collaborate with our diagnostic partners, ZeptoMetrix takes pride in the role PROtrol plays in increasing global access to diagnostic testing.”

For more details on ordering the new PROtrol and other ZeptoMetrix products, please visit: https://www.zeptometrix.com

About ZeptoMetrix® ZeptoMetrix® holds a distinguished position as an industry leader in designing, developing, and delivering innovative and high-quality solutions to the infectious disease diagnostics market. Leveraging our expertise in molecular diagnostics, including external quality controls, verification panels, proficiency panels, and customized/OEM products and services, we have set the benchmark for performance and reliability. ZeptoMetrix is the trusted choice for independent third-party quality control materials.

Contact Information

Andrew Zenger
Global Product Manager
andrew.zenger@antylia.com
(716) 715-7417

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from up to 5 devices at once

Latest stories

LEAVE A REPLY

Please enter your comment!
Please enter your name here